Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,821,139
-$44,588,441 QoQ
Shares Held
43,857
-92.7% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#113
of 285 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Derivatives in APGE
reported options exposure · as of Jun 30, 2026CallValue
$929,110
CallShares
7,000
PutValue
$1,061,840
PutShares
8,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. APGE ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in APGE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $929,110 | 7,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,061,840 | 8,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $5,821,139 | 43,857 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $50,409,580 | 598,902 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $2,836,529 | 33,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,683,400 | 20,000 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,071,816 | 14,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $57,891,724 | 766,981 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $1,192,584 | 15,800 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $46,454,063 | 1,169,244 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $297,975 | 7,500 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $814,465 | 20,500 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $21,526,470 | 495,659 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $503,788 | 11,600 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $2,472,559 | 66,182 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $291,408 | 7,800 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $750,936 | 20,100 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $3,294,397 | 72,724 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $140,430 | 3,100 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $117,780 | 2,600 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $29,370 | 500 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $487,542 | 8,300 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $86,570 | 2,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $4,577,113 | 116,318 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $291,190 | 7,400 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $338,895 | 5,100 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $13,290 | 200 | Call | Defined | 2024-05-15 | |
| 2023-09-30 | $5,178,583 | 243,126 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||